Consensus Guidelines on Improving the Management of HAE

Accreditation Information

Target Audience

This on-line enduring material educational activity is intended for Physicians, Pharmacists, Nurses and other health care professionals who treat patients with HAE. 

Educational Goal/Purpose 

The purpose of this program is to provide attendees with the necessary tools to correctly diagnose and treat patients with HAE. 

Learning Objectives

After participating in this educational activity, learners should be able to: 

  1. Recognize the pathophysiologic differences between HAE-related angioedema and other forms of angioedema 
  2. Apply strategies to assist HAE patients in managing and seeking treatment for acute episodes of HAE 
  3. Evaluate treatment options and patient considerations, and incorporate them into patient-centric care plans for the acute management of an HAE episode 
  4. Explain the array of available treatment guidelines, understand their similarities and differences, and how this information is best applied in practice 
  5. Recognize the low but permanent risk of asphyxiation in patients with HAE and the frequency with which it occurs in both the diagnosed and undiagnosed HAE population

Planner Disclosures

No member of CMEsolutions or CE Symmetry has any relevant financial relationships to disclose.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and CE Symmetry. CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The CMEsolutions designates this live activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE: The CMEsolutions is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1 contact hours 0.1 CEUs. ACPE Program Number: 0274-9999-17-023-H04-P.

* Important Notice and Instructions: Beginning January 1, 2013, participants requesting ACPE credit must complete the information requested. CMEsolutions will upload credit completion information to the CPE Monitor within 6 weeks following the activity. The CPE Monitor System will direct electronic data submitted by ACPE-accredited providers to ACPE and to NABP, ensuring that CPE credit is officially verified by providers. Once information is received by NABP, pharmacists and pharmacy technicians will be able to log in and access information about completed CPE activities.

ANCC: To obtain Nursing CE for this program, participants must complete the program requirements listed below and request an ACCME certificate. The certificate should then be submitted to the state board of nursing for the participant.


There are no fees for participation in this activity. 

Activity Start Date

August 9, 2017 

Activity End Date

August 9, 2019 

Participation Requirements

Off-label Use

Consensus Guidelines on the Management of HAE may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.

Commercial Support 

There is no commercial support for this activity. 

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy:

CMEsolutions can be contacted at

Faculty and Disclosures

CMEsolutions has resolved all conflicts of interest prior to this educational activity through the following procedures: